Who
Diane C. Young
SVP, Chief Medical Officer
Company insider
Files Form 4 as: SVP, Chief Medical Officer, Celldex Therapeutics; VP, Chief Medical Officer, Gtx Inc /de/.
In numbers
- Trades disclosed
- 30
- Buys
- 1
- Sells
- 6
- Bought
- $10K
- Sold
- $2.6M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 13 Jul 2015
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —57,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —57,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —72,000 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —72,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $41K15,000 at $2.71 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $1.6M45,000 at $35.26 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 17 Aug 2022filed 19 Aug 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —19,000 at $0.00 | filing |
| 17 Aug 2022filed 19 Aug 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —45,000 at $0.00 | filing |
| 17 Aug 2022filed 19 Aug 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $197K19,000 at $10.38 | filing |
| 17 Aug 2022filed 19 Aug 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $709K19,000 at $37.30 | filing |
| 17 Aug 2022filed 19 Aug 2022 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $122K45,000 at $2.71 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —76,000 at $0.00 | filing |
| 12 Nov 2021filed 16 Nov 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,600 at $0.00 | filing |
| 12 Nov 2021filed 16 Nov 2021 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $48K4,600 at $10.38 | filing |
| 12 Nov 2021filed 16 Nov 2021 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Sold | $198K4,600 at $42.94 | filing |
| 17 Jun 2021filed 21 Jun 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —72,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —72,000 at $0.00 | filing |
| 11 Jun 2020filed 12 Jun 2020 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Bought | $10K2,115 at $4.73 | filing |
News
No headline names them, or the companies they trade most, lately.